Table 3 The relationship between the preoperative risk grade and the clinicopathological characteristics
Variables | Preoperative risk grade | p | ||
|---|---|---|---|---|
0 n = 84 | 1 n = 196 | 2 n = 188 | ||
Age | 58 (50–65) | 59 (52–64) | 58 (50–66) | 0.623 |
Gender (male) | 50 (59.5%) | 112 (57.1%) | 120 (63.8%) | 0.404 |
Smoking (yes v no) | 32 (38.1%) | 54 (27.6%) | 46 (24.5) | 0.067 |
Drinking (yes) | 16 (19.0%) | 30 (15.3%) | 20 (10.6) | 0.150 |
HBsAg (positive) | 46 (54.8%) | 92 (46.9%) | 64 (34.0%) | 0.002 |
ALT (U/L) | 21 (15–37) | 29 (16–65) | 36 (17–88) | < 0.001 |
ALB (g/L) | 38.5 (35.6.2–41.3) | 34.1 (33.2–38.2) | 30.7 (29.20–34.6) | < 0.001 |
TBIL (μmol/L) | 11.6 (8.7–15.4) | 13.9 (9.1–22.5) | 13.4 (8.9–82.5) | < 0.001 |
Child–Pugh grade (B) | 4 (4.8%) | 52 (26.5%) | 70 (37.2%) | < 0.001 |
Cirrhosis (yes) | 42 (50.0%) | 82 (41.8%) | 98 (52.1%) | 0.114 |
LMR | 4.4 (3.1–5.4) | 3.4 (1.8–4.4) | 2.6 (1.3–3.5) | < 0.001 |
NLR | 1.97 (1.38–2.51) | 2.3 (1.6–3.3) | 3.1 (2.2–5.2) | < 0.001 |
PLR | 87.4 (75.7–115.8) | 127.7 (94.0–197.8) | 234.7 (185.2–274.5) | < 0.001 |
Log10 AFP | 0.66 (0.44–1.84) | 0.51 (0.32–0.72) | 0.51 (0.35–1.09) | 0.020 |
Log10 CEA | 0.29 (0.10–0.45) | 0.49 (0.25–0.61) | 0.49 (0.33–0.70) | < 0.001 |
Log10 CA19-9 | 1.56 (1.05–2.33) | 1.91 (1.34–2.77) | 2.21 (1.45–2.97) | < 0.001 |
Tumor number (multiple) | 20 (23.8%) | 42 (21.4%) | 45 (23.9%) | 0.821 |
Tumor diameter (> 5 cm) | 50 (59.5%) | 90 (45.9%) | 68 (36.2%) | 0.001 |
VI (yes) | 6 (7.1%) | 40 (20.4%) | 54 (28.7%) | < 0.001 |
Lymph node metastasis (yes) | 16 (19.0%) | 54 (27.6%) | 88 (46.8%) | < 0.001 |
Tumor differentiation | Â | Â | Â | 0.989 |
 Well | 6 (7.1%) | 16 (8.2%) | 14 (7.4%) |  |
 Moderate | 62 (73.8%) | 146 (74.5%) | 138 (73.4%) |  |
 Poor | 16 (19.0%) | 34 (17.3%) | 36 (19.1%) |  |
Adjuvant chemotherapy (yes) | 22 (26.2%) | 38 (19.4%) | 30 (16.0%) | 0.141 |
Type of hepatectomy (major) | 48 (57.1%) | 106 (54.1%) | 102 (54.3%) | 0.884 |
Blood transfusion (yes) | 16 (19.0%) | 58 (29.6%) | 60 (31.9%) | 0.088 |